Product Information

CITALOPRAM HBR 10 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.0300 per EA under NDC 13668000905. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CITALOPRAM HBR 10 MG TABLET

Citalopram
$0.0300per EA

Strength

10 mg/1

NDC

13668000905

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CITALOPRAM HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078216

FDA Approved

3/27/2007

TE Code

AB

On Market Since

10/18/2007

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for CITALOPRAM HBR 10 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0300 per EA
All-time high$0.0389 (Feb 12, 2014)
All-time low$0.0204 (May 22, 2024)
52-week high$0.0300
52-week low$0.0241
Median price$0.0277
Average price$0.0291
Largest weekly change+24.2% (Jun 19, 2024)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+5.0%

1M

+15.2%

3M

+21.8%

6M

+17.4%

1Y

+25.0%

3Y

+14.5%

5Y

+14.1%

All

-12.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CITALOPRAM HBR 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 10 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $0.0300 per EA (NDC 13668000905), effective Nov 18, 2026.

How has the price of CITALOPRAM HBR 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for CITALOPRAM HBR 10 MG TABLET has declined 12.3%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 10 MG TABLET?

Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 10 MG TABLET has ranged from a low of $0.0204 (May 22, 2024) to a high of $0.0389 (Feb 12, 2014), with a median of $0.0277 per EA.

Are there cheaper alternatives to CITALOPRAM HBR 10 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CITALOPRAM HBR 10 MG TABLET, is $0.0261 per EA — about 13% below CITALOPRAM HBR 10 MG TABLET.

Who manufactures CITALOPRAM HBR 10 MG TABLET?

CITALOPRAM HBR 10 MG TABLET (NDC 13668000905) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.